Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Nov 13 - Nov 18
Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects
Mechanotransduction pathways, which convert mechanical loading signals into cellular repair activity, appear more responsive in BPC-157-treated tissue according to animal studies, suggesting a coordinated improvement across multiple cellular mechanisms driving tendon regeneration
The peptide has a short half-life of less than 30 minutes and is rapidly metabolized, which means consistent dosing protocols matter significantly
Injectable BPC-157 bypasses the digestive system and enters the bloodstream directly
US$ 23.81
US$ 20.52
US$ 27.01
US$ 23.90
US$ 26.12
US$ 29.56
